Nachrichten zur RaySearch Laboratories AB Aktie

RaySearch Laboratories to present ongoing development in liver ablation therapy* at RSNA 2024

RaySearch will be exhibiting its advanced software solutions at RSNA in Chicago, Illinois, December 1 – 4. RSNA is the…

Institut Curie selects RayStation for proton planning

RaySearch Laboratories AB (publ) is pleased to announce that Institut Curie, spread over three radiotherapy centers, located in Paris, Orsay,…

RaySearch appoints new CFO

RaySearch Laboratories AB (publ) announces that Nina Grönberg has been appointed new CFO of the company, taking up her position…

Another three centers under the French Unicancer framework select RayStation

RaySearch Laboratories AB (publ) is pleased to announce that Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier…

RaySearch has more than 100 RayStation customers in China

RaySearch Laboratories AB (publ) is proud to announce that the number of radiotherapy centers in China using RayStation®* for treatment…

GenesisCare UK selects RayStation

RaySearch Laboratories AB (publ) is pleased to announce that GenesisCare UK has placed an order for the RayStation®* treatment planning…

RaySearch’s CEO sells shares – remains a long-term shareholder

RaySearchs founder and CEO, Johan Löf, has sold 150,000 Class B shares in RaySearch Laboratories AB (publ) on September 24,…

Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient

RaySearch Laboratories AB (publ) is pleased to announce that Iridium Network in Belgium has treated its first patient using RaySearch’s…

Connecticut Proton Therapy Center selects RayCare

RaySearch Laboratories AB (publ) is pleased to announce that the Connecticut Proton Therapy Center, Wallingford, Connecticut, USA, has placed an…

RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system

RaySearch Laboratories AB (publ) is pleased to announce a milestone in radiotherapy technology where RaySearch’s RayStation®* was used for the…

RaySearch celebrating 10 years of defining state-of-the-art proton planning at PTCOG 62

RaySearch Laboratories AB (publ) will kick off its tenth-anniversary celebration at the Particle Therapy Cooperative Group (PTCOG) Conference in Singapore,…

RaySearch releases RayCare 2024A

RaySearch Laboratories AB (publ) announces the release of the latest version of RayCare®*, the next generation oncology information system. RayCare…

Bulletin from the Annual General Meeting 2024

The Annual General Meeting 2024 of RaySearch Laboratories AB (publ) was held on May 22, 2024 in Stockholm, Sweden. The…

RaySearch and C-RAD sign collaboration agreement

RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and…

Invitation to Annual General Meeting 2024

The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to…

World leading carbon ion center QST in Japan selects RayStation

RaySearch Laboratories AB (publ) announces that QST, National Institutes for Quantum Science and Technology in Chiba, Japan, has selected the…

RaySearch to present latest innovations in RayStation, RayCare and RayIntelligence at ISOP and NPC (NAPT)

RaySearch Laboratories AB (publ) will present the latest software innovations at IBA’s International Symposium on Proton Therapy (ISOP) in Boston,…

Pharmacolog divests part of its operations to RaySearch Laboratories AB

Pharmacolog AB (Publ) announces today that the company will divest its product line Druglog™ to RaySearch Laboratories AB through a so-called…

The Froedtert & Medical College of Wisconsin health network selects RayStation

RaySearch Laboratories AB (publ) announces that the Froedtert & Medical College of Wisconsin health network, USA, has placed an order…

Vejle Hospital becomes first center in the world to use RayStation for an online adaptive treatment with augmented CBCT

RaySearch Laboratories AB (publ) announces that University Hospital of Southern Denmark in Vejle, Denmark has developed a new and groundbreaking…

Oregon Health & Science University (OHSU) to utilize RayStation technology for radiation therapy planning

RaySearch Laboratories AB (publ) announces that Oregon Health & Science University (OHSU) in the USA has placed an order for…

Baptist Health Lexington selects RayStation

RaySearch Laboratories AB (publ) announces that Baptist Health Lexington, Kentucky, USA, has begun implementation of the treatment planning system RayStation®*. RayStation…

Prominent U.S. hospital expands RayStation installation for proton treatment planning

RaySearch Laboratories AB (publ) announces that the Mass General Cancer Center plans to expand its use of RayStation®* to proton…

RaySearch and Mevion – A synergy of innovation transforming proton therapy

RaySearch Laboratories AB (publ) is proud to announce the continued commitment with Mevion Medical Systems, the leading global provider of…

Paul Scherrer Institute selects RayStation

RaySearch Laboratories AB (publ) is pleased to announce that the Paul Scherrer Institute (PSI) in Switzerland has placed an order…

RaySearch deepens collaboration with P-Cure

RaySearch Laboratories AB (publ) is pleased to announce its expanded collaboration with P-Cure, aiming at enhancing the workflow efficiency of…

RaySearch receives order for RayStation and RayCare in Italy

RaySearch Laboratories AB (publ) announces that Ion Beam Applications S.A. (IBA), market leader in proton therapy, has placed an order…

RaySearch and MedAustron expand their partnership

RaySearch Laboratories AB (publ) is pleased to announce that the longterm collaboration/partnership with the innovative center EBG MedAustron GmbH in…

RaySearch Laboratories reports Q2 results

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

RaySearch Laboratories : Interim report January 1 - June 30, 2023

STOCKHOLM, Aug. 25, 2023 /PRNewswire/ -- SECOND QUARTER (APRIL-JUNE 2023) Order intake SEK 239.2 M (212.5) Net sales SEK 239.5…

RaySearch to present the latest advances in RayStation, RayCare and RayIntelligence at AAPM 2023

RaySearch will be showcasing the latest software innovations at AAPM in Houston, Texas, July 23-27. Attendees will be able to…

RaySearch releases RayCare 2023B

RaySearch Laboratories AB (publ) announces the release of the latest version of RayCare®*, the next generation oncology information system. RayCare®…

RaySearch releases RayStation 2023B

RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2023B, the latest version of the companys comprehensive oncology treatment planning…

Southwest Florida Proton selects RayStation

RaySearch Laboratories AB (publ) announces that Southwest Florida Proton, USA, has placed an order for the treatment planning system RayStation®*…

Henrik Bergentoft leaves the position as CFO for RaySearch

STOCKHOLM, July 7, 2023 /PRNewswire/ -- Henrik Bergentoft has decided to leave the position as CFO of RaySearch Laboratories AB…

Henrik Bergentoft leaves the position as CFO for RaySearch

Henrik Bergentoft has decided to leave the position as CFO of RaySearch Laboratories AB (publ) for new challenges. Annika Blondeau…

Share conversion in RaySearch Laboratories AB (publ)

According to the articles of association of RaySearch Laboratories AB (publ), owners of Class A shares have the right to…

The Australian Bragg Centre for Proton Therapy and Research selects RayCare

RaySearch Laboratories AB (publ) announces that the Australian Bragg Centre for Proton Therapy and Research (ABCPTR) in Adelaide, Australia has…

RaySearch signs agreement with Shinva for large order in China

RaySearch Laboratories AB (publ) is pleased to announce an agreement with the Chinese radiation therapy machine manufacturer Shinva. Shinva has…

RaySearch signs agreement with B dot Medical for development of advanced software solutions for proton therapy

RaySearch Laboratories AB (publ) is pleased to announce a strategic collaboration agreement with B dot Medical Inc. aimed at advancing…

RaySearch to exhibit the latest software innovations for particle therapy and BNCT at PTCOG 2023

RaySearch Laboratories AB (publ) will exhibit at PTCOG 61 (https://www.ptcog61.org/), to be held in Madrid, Spain, June 10-16. The latest news…

Bulletin from the Annual General Meeting 2023

The Annual General Meeting 2023 of RaySearch Laboratories AB (publ) was held on May 25, 2023 in Stockholm, Sweden. The…

RayCare is interoperable with Varian TrueBeam

RaySearch Laboratories AB (publ) is proud to announce that the oncology information system RayCare®* can connect to Varian TrueBeam® linear…

RaySearch expands collaboration with BEBIG Medical

RaySearch Laboratories AB (publ) is pleased to announce that the strategic partnership with BEBIG Medical, which began in 2018, has…

RaySearch to present the latest advances in RayStation, RayCare and RayIntelligence at ESTRO 2023

RaySearch will be showcasing the latest software innovations at ESTRO in Vienna, May 12-15. Attendees will be able to book…

RayStation to replace existing treatment planning system at New York University Langone Hospital – Long Island

RaySearch Laboratories AB (publ) announces that New York University (NYU) Langone Hospital – Long Island in Mineola, New York, has…

RaySearch publishes Annual Report for 2022

STOCKHOLM, April 28, 2023 /PRNewswire/ -- Today, RaySearch Laboratories AB (publ) publishes its Annual Report for the financial year 2022.…

RaySearch publishes Annual Report for 2022

Today, RaySearch Laboratories AB (publ) publishes its Annual Report for the financial year 2022. The report is held available on…

RaySearch publishes the annual report for 2022 on April 28

RaySearch Laboratories AB (publ) announces that the date for publication of the annual report for 2022 will be April 28.…

RaySearch publishes the annual report for 2022 on April 28

STOCKHOLM, April 26, 2023 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces that the date for publication of the annual report…